Mexico vs Suriname: Cause of death, by non-communicable diseases, female
Mexico
59.5%
in 2021
Suriname
60.5%
in 2021
Mexico rank
124th
Suriname rank
122nd
Cause of death, by non-communicable diseases, female over time
- Mexico
- Suriname
How they compare
Suriname currently reports 60.5% against 59.5% in Mexico, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Mexico ahead.
Mexico ranks 124th and Suriname ranks 122nd of 185 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Suriname in 1.
Head to head by decade
| Decade | Mexico | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.2% | 65.1% | 11.1% | Mexico |
| 2010s | 84.1% | 78.3% | 5.8% | Mexico |
| 2020s | 60.8% | 69.8% | 9.0% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Mexico or Suriname?
- Suriname, at 60.5% against 59.5% in Mexico as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Mexico and Suriname?
- 1.0%, with Suriname ahead.
- How many years of comparable data are there for Mexico and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Mexico and Suriname rank globally for cause of death, by non-communicable diseases, female?
- Mexico ranks 124th and Suriname ranks 122nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.